IgG4(MRQ-44),MMab

igG4 is a low-proportion lgG subtype, accounting for only 3% to 6% of total lgG in normal human serum. lgG4related sclerosing disease is a recently recognized syndrome characterized by tumor-like lesions in multiple organsincluding the pancreas, bile ducts, gallbladder, lacrimal glands, salivary glands, retroperitoneum, kidneys, lungsbreast, thyroid, and prostate. Histologically, these lesions show dense infiltration of ivmphocytes and plasma celsalong with stromal sclerosis. Patients typically exhibit elevated serum lgG4 titers and increased lgG4-positive plasmacells in affected tissues. The condition often responds well to steroid therapy and is associated with a favorableclinical prognosis. lmmunohistochemical studies of igG4-related sclerosing disease have shown a marked increase inlgG4-positive cells in lesional tissues, as well as a significantly elevated lgG4/lgG ratio.

IgG4(MRQ-44),MMab
IgG4(MRQ-44),MMab

Intended Use

igG4 is a low-proportion lgG subtype, accounting for only 3% to 6% of total lgG in normal human serum. lgG4related sclerosing disease is a recently recognized syndrome characterized by tumor-like lesions in multiple organsincluding the pancreas, bile ducts, gallbladder, lacrimal glands, salivary glands, retroperitoneum, kidneys, lungsbreast, thyroid, and prostate. Histologically, these lesions show dense infiltration of ivmphocytes and plasma celsalong with stromal sclerosis. Patients typically exhibit elevated serum lgG4 titers and increased lgG4-positive plasmacells in affected tissues. The condition often responds well to steroid therapy and is associated with a favorableclinical prognosis. lmmunohistochemical studies of igG4-related sclerosing disease have shown a marked increase inlgG4-positive cells in lesional tissues, as well as a significantly elevated lgG4/lgG ratio.


[Storage and Validity]

Store at 2~8°C. Avoid freezing. 
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.


Specification

Product Name

IgG4(MRQ-44),MMab

Clone

MRQ-44

Catalog No.

CIM-0130

Positive Site

Cytoplasm

Applicable Tissue

Paraffin section

Pre-treatment

Heat retrieval

Format and Volume

Ready-to-use: 1mL, 3mL, 6mL 


  • Intended Use

  • Specification

Related Products

Tel

Tel

4012094076
Email

Email

info@celnovte.com
Celnovte

Top

Partner with Celnovte

Partner with Celnovte

Elevate Your IHC Business with Proven Solutions & Global Support.

Contact us Celnovte
增长建设站